Home/Filings/4/0001493152-25-025198
4//SEC Filing

Samuelson Doug 4

Accession 0001493152-25-025198

CIK 0001962011other

Filed

Nov 25, 7:00 PM ET

Accepted

Nov 26, 5:24 PM ET

Size

5.1 KB

Accession

0001493152-25-025198

Insider Transaction Report

Form 4
Period: 2025-10-08
Samuelson Doug
Chief Financial Officer
Transactions
  • Award

    COMMON STOCK

    2025-10-08+152,672293,039 total
Footnotes (2)
  • [F1]Represents 152,672 restricted stock units ("RSUs") issued to the Reporting Person under the Kairos Pharma, Ltd. 2023 Equity Incentive Plan. The 152,672 RSUs are scheduled to vest in full on the first anniversary of the grant date.
  • [F2]Consists of (1) 140,367 shares of common stock and (2) 152,672 RSUs which remain subject to vesting.

Documents

1 file

Issuer

Kairos Pharma, LTD.

CIK 0001962011

Entity typeother

Related Parties

1
  • filerCIK 0001943326

Filing Metadata

Form type
4
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 5:24 PM ET
Size
5.1 KB